Brain MRI in mucopolysaccharidosis: Effect of aging and correlation with biochemical findings

Neurology

Volumn 69, Issue 9, 2007, Pages 917-924

  Vedolin, L ^a,e   Schwartz, I V D ^b,c   Komlos, M ^a   Schuch, A ^c   Azevedo, A C ^b   Vieira, T ^b   Maeda, F K ^d   Marques Da Silva, A M ^d   Giugliani, R ^b,c  

^a HOSPITAL MÃE DE DEUS   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLYCOSAMINOGLYCAN; INOSITOL; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AGING; ARTICLE; BIOCHEMICAL COMPOSITION; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOPOLYSACCHARIDOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; AGING; BRAIN; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENZYMES; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUCOPOLYSACCHARIDOSES; MUCOPOLYSACCHARIDOSIS II; NERVE FIBERS, MYELINATED; PREDICTIVE VALUE OF TESTS;

EID: 34548203201     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000269782.80107.fe     Document Type: Article

References (32)

1. Scriver CR. The metabolic and molecular bases of inherited disease. 8th ed. Vol 3. New York: McGraw-Hill, 2001:3421-3452.
2. Harmatz P, Whitley CB, Waber L, et al. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr 2004;144:574-580.
3. Hopwood JJ, Vellodi A, Scott HS, et al. Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J Inherit Metab Dis 1993;16:1024-1033.
4. Kakkis ED, Muenzer J, Tiller GE, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001;344:182-188.
5. Wraith JE. Lysosomal disorders. Semin Neonatol 2002;7:75-83.
6. Cheon JE, Kim IO, Hwang YS, et al. Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics 2002;22:461-476.
7. Faerber EN, Poussaint TY. Magnetic resonance of metabolic and degenerative diseases in children. Top Magn Reson Imaging 2002;13:3-21.
8. Zafeiriou DI, Savvopoulou-Augoustidou PA, Sewell A, et al. Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B). Brain Dev 2001;23:385-389.
9. Seto T, Kono K, Morimoto L, et al. Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 2001;50:79-92.
10. Lee C, Dineen TE, Brack M, Kirsch JE, Runge VM. The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR 1993;14:1285-1292.
11. Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiol 2004;46:666-672.
12. Gabrielli O, Polonara G, Regnicolo L, et al. Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet A 2004;125:224-231.
13. Takahashi Y, Sukegawa K, Aoki M, et al. Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res 2001;49:349-355.
14. Barkovich AJ. Pediatric neuroimaging. 3rd ed. Philadelphia: LWW, 2000.
15. Barone R, Parano E, Trifiletti RR, Fiumara A, Pavone P. White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: characterization by MRI. J Neurol Sci 2002;195:171-175.
16. McGraw P, Liang L, Escolar M, Mukundan S, Kurtzberg K, Provenzale JM. Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements-initial experience. Radiology 2005;236:221-230.
17. Taccone A, Tortori Donati P, Marzoli A, et al. Mucopolysaccharidoses: evaluation of the cranium by computed tomography and magnetic resonance. Radiol Med 1992;84:236-241.
18. Shinomiya N, Nagayama T, Fujioka Y, Aoki T. MRI in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiol 1996;38:483-485.
19. Sheridan M, Johnston I. Hydrocephalus and pseudotumour cerebri in the mucopolysaccharidoses. Childs Nerv Syst 1994;10:148-150.
20. Murata R, Nakajima S, Tanaka A, et al. MR imaging of the brain in patients with mucopolysaccharidosis. AJNR 1989;10:1165-1170.
21. Kulkarni MV, Williams JC, Yeakley JW, et al. Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses. Magn Reson Imaging 1987;5:317-323.
22. Dickerman RD, Colle KO, Bruno CA Jr, Schneider SJ. Craniovertebral instability with spinal cord compression in a 17-month-old boy with Sly syndrome (mucopolysaccharidosis type VII): a surgical dilemma. Spine 2004;29:E92-E94.
23. Barone R, Nigro F, Triulzi F, et al. Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 1999;30:270-274.
24. Parsons VJ, Hughes DG, Wraith JE. Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin Radiol 1996;51:719-723.
25. Fuller M, Rozaklis T, Ramsay SL, Hopwood JJ, Meikle PJ. Disease-specific markers for the mucopolysaccharidoses. Pediatr Res 2004;56:733-738.
26. Fuller M, Brooks DA, Evangelista M, Hein LK, Hopwood JJ, Meikle PJ.. Prediction of neuropathology in mucopolysaccharidosis I patients. Mol Genet Metab 2005;84:18-24.
27. Azevedo AC, Schwartz IV, Kalakun L, et al. Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI. Clin Genet 2004;66:208-213.
28. Savas PS, Hemsley KM, Hopwood JJ. Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA. Mol Genet Metab 2004;82:273-285.
29. Ohmi K, Greenberg DS, Rajavel KS, et al. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 2003; 100:1902-1907.
30. Ferrer I, Cusi V, Pineda M, Galofre E, Vila J. Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III: a Golgi and ultrastructural study. Neuropathol Appl Neurobiol 1988;14:315-323.
31. Dinopoulos A, Gorospe JR, Egelhoff JC, et al. Discrepancy between neuroimaging findings and clinical phenotype in Alexander disease. AJNR 2006;(27):2088-2092.
32. Walkley SU, Thrall MA, Haskings ME, et al. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease. Neuropathol Appl Neurobiol 2005;31:536-544.